Filing Details
- Accession Number:
- 0001127602-23-022961
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-18 17:05:02
- Reporting Period:
- 2023-08-16
- Accepted Time:
- 2023-08-18 17:05:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1531048 | Inari Medical Inc. | NARI | Surgical & Medical Instruments & Apparatus (3841) | 452902923 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1806431 | Andrew Hykes | C/O Inari Medical, Inc. 6001 Oak Canyon Irvine CA 92618 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-08-16 | 18,166 | $65.31 | 493,642 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-08-16 | 8,009 | $66.32 | 485,633 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-08-16 | 9,906 | $67.31 | 475,727 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-08-16 | 595 | $68.03 | 475,132 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,550 | Indirect | By Child 1 |
| Common Stock | 1,550 | Indirect | By Child 2 |
| Common Stock | 1,550 | Indirect | By Child 3 |
| Common Stock | 1,000 | Indirect | By Spouse |
Footnotes
- Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person.
- This transaction was executed in multiple trades at prices ranging from $64.88 to $65.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $65.88 to $66.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $66.88 to $67.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $67.89 to $68.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Includes 199 shares acquired on July 31, 2023, under the Company's Employee Stock Purchase Plan.
Billionaire Hedge Funds
